insights_auto
Why is HAE down 2.48%?
Dive Deeperchevron_right
HAE:NYSE
Haemonetics Corp
$118.28
arrow_downward
-2.48%(-3.01) 1D
$118.52
arrow_upward
+0.20% (+0.24)bedtimeAfter hours
Closed: Oct 16, 4:00:07 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$121.83
High
$121.84
Low
$118.19
Mkt. cap
5.38B
Avg. vol.
685.54K
Volume
471.52K
P/E ratio
57.69
52-wk high
$123.77
52-wk low
$48.98
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
Open
$121.83
High
$121.84
Low
$118.19
Mkt. cap
5.38B
Avg. vol.
685.54K
Volume
471.52K
P/E ratio
57.69
52-wk high
$123.77
52-wk low
$48.98
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Haemonetics Gains 149.3% in a Year: What's Driving the Rally?
Yahoo Finance
·
2 days ago
Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorMedical device
Websitehaemonetics.com